
ALVO
Healthcare · Drug Manufacturers - Specialty & Generic · $1.50B market cap
$4.19-0.48 (-10.3%)Nov 13, 4:00 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -755.1% over 90 days · 30-day revisions 0 up, 1 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 11, 2026 | After the close | -0.01 | -0.03 | -200.0% |
| Aug 19, 2026 | After the close | -0.06 | -0.11 | -83.3% |
| May 5, 2026 | After the close | -0.07 | -0.09 | -28.6% |
| Mar 18, 2026 | Time not confirmed | -0.08 | 0.01 | +112.0% |
| Nov 12, 2025 | After the close | -0.03 | -0.11 | -266.7% |
| Aug 13, 2025 | After the close | -0.00 | 0.03 | +1404.3% |
| May 7, 2025 | Time not confirmed | 0.03 | 0.35 | +1066.7% |
| Mar 26, 2025 | After the close | -0.03 | -0.24 | -700.0% |
| Nov 13, 2024 | After the close | -0.06 | -0.48 | -700.0% |
| Aug 15, 2024 | After the close | -0.02 | 0.18 | +1000.0% |
| May 21, 2024 | After the close | -0.08 | -0.89 | -1012.5% |
| Mar 20, 2024 | After the close | -0.07 | -1.22 | -1642.9% |
| Nov 28, 2023 | After the close | -0.07 |
Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company provides AVT02, a high concentration, low-volume adalimumab formulation biosimilar to Humira to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic…
| -0.82 |
| -1071.4% |
| Aug 30, 2023 | After the close | -0.14 | -0.14 | 0.0% |
| May 19, 2023 | Before the open | -1.24 | -1.24 | 0.0% |
| Mar 1, 2023 | After the close | 0.00 | -1.51 | — |
| Nov 15, 2022 | After the close | 0.02 | -0.03 | -273.0% |
| Aug 31, 2022 | After the close | 0.00 | -0.74 | — |
| May 16, 2022 | After the close | — | -3.25 | — |
| Mar 30, 2022 | After the close | — | -0.13 | — |
| Nov 15, 2021 | After the close | — | 0.04 | — |
| Aug 16, 2021 | After the close | — | -0.01 | — |
| May 20, 2021 | After the close | — | 0.23 | — |
| Mar 31, 2021 | After the close | — | -0.30 | — |